FEDERAL JOB CUTS THREATEN PUBLIC HEALTH SECURITY AND TALENT
The recent wave of federal job cuts, particularly within the Department of Health and Human Services (HHS), has caused significant disruption, especially at the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). Around 1,200 NIH employees, including promising young investigators, were dismissed, along with reductions in CDC training programs. These firings, aimed at streamlining the federal workforce, have raised concerns about the loss of talent, particularly in public health fields that are vital to the nation’s security. The cuts come amid an ongoing public health crisis, with a recent fatality from bird flu in Louisiana. Experts warn that these cuts jeopardize the nation’s preparedness for future health emergencies. The dismissals also affect graduate students and professionals, including those working on maternal health and disease investigations. Critics argue that the government’s approach lacks a strategic focus and risks undermining public service in critical health sectors. (New York Times)
FDA FIRINGS JEOPARDIZE NEURALINK TRIALS AND MEDICAL DEVICE OVERSIGHT
Around 20 U.S. Food and Drug Administration (FDA) employees who reviewed applications from Elon Musk’s brain implant company, Neuralink, were fired as part of a broader federal workforce reduction. These employees were part of the FDA’s office overseeing clinical trial applications for brain-computer interface devices like Neuralink’s. While the firings were not directly tied to their work on Neuralink, experts warn that losing these professionals will hinder the FDA’s ability to process medical device applications, including those from Neuralink. The cuts, which primarily affected probationary employees, are seen as part of Musk’s broader efforts to reduce government spending. Neuralink is testing a device that allows paralyzed individuals to control digital devices with their thoughts and is working on an implant for vision restoration. The dismissals, which cited performance issues despite top evaluations, have raised concerns about the safety and oversight of ongoing clinical trials. (Reuters)
H5N1 AVIAN FLU SPILLOVER INTO DAIRY CATTLE RAISES CONCERNS
National milk testing has detected another H5N1 avian influenza spillover into dairy cows in Arizona’s Maricopa County. The affected herd showed no symptoms, and the virus is identified as the D1.1 genotype, which is prevalent in North American wild birds and has caused poultry outbreaks. This is the third such introduction into dairy cattle. Agriculture officials also issued warnings about raw pet food after H5N1 was linked to illnesses in two domestic cats in Oregon, both of which had eaten the same contaminated food. Meanwhile, the USDA has conditionally approved a vaccine for H5N2 avian flu in poultry by Zoetis. This approval may provide an additional tool to combat the ongoing surge of H5N1 outbreaks in commercial poultry, which have led to the loss of over 162 million birds since 2022, contributing to egg shortages and high prices. (CIDRAP)
REPUBLICANS PROPOSE MEDICAID CUTS AMIDST FEDERAL SPENDING DEBATE
Republicans are considering significant cuts to Medicaid, a program that provides health care to 80 million U.S. adults and children, as part of efforts to reduce federal spending. The GOP is focusing on work requirements and proposals to shift Medicaid funding to fixed per-person rates, which could strain state budgets. Some states, like Arkansas and Ohio, have already implemented Medicaid work rules, which critics argue can result in coverage loss due to bureaucratic hurdles. Meanwhile, proposed cuts could also affect the Affordable Care Act’s navigator program, which helps people enroll in Medicaid and ACA coverage. Republican leaders argue that work requirements will encourage employment, but research shows that most Medicaid recipients are already working, attending school, or caregiving. Democrats warn that these cuts could harm vulnerable populations and lead to closures of health facilities, especially in rural areas, where Medicaid expansion has been critical for access to care. (AP)
GIRL REMAINS CANCER-FREE AFTER 19 YEARS WITH CAR T-CELL THERAPY
A remarkable case published in Nature Medicine on February 17 highlights the longest reported cancer remission following CAR T-cell therapy. The story centers on a girl who, at four years old, received the experimental treatment for nerve-cell cancer (neuroblastoma) that had spread to her bones. After standard treatments failed, she was given CAR T cells in 2006 and has remained cancer-free for 19 years, becoming a mother of two. CAR T cells, which engineer immune cells to target cancer cells, have shown success in treating blood cancers like leukemia, but progress in treating solid tumors, like neuroblastoma, has been slower. This study provides hope for expanding CAR T-cell therapy to solid tumors. Although early trials were mixed, with only some children responding positively, the results are encouraging. Researchers are now refining CAR T-cell formulations for more consistent outcomes, but much work remains to be done in this area. (Nature)
POPE FRANCIS REMAINS HOSPITALIZED DUE TO RESPIRATORY INFECTION
Pope Francis, 88, spent a “peaceful” fourth night in the hospital after being admitted for a respiratory infection that has lasted over a week. On Tuesday, he had breakfast and read newspapers, as he often does. Due to his continued illness, the Vatican canceled his weekend commitments, including the Jubilee audience scheduled for February 22. The pontiff’s health was described as being affected by a polymicrobial infection of the respiratory tract, which involves multiple microorganisms like bacteria, viruses, or fungi. Tests indicated a complex clinical condition, necessitating an extended hospital stay. A medical update is expected later in the day. (The Guardian)
POPE FRANCIS REMAINS HOSPITALIZED DUE TO RESPIRATORY INFECTION
Johnson & Johnson (J&J) is facing a critical decision in a Texas bankruptcy court over its $10 billion proposal to end lawsuits alleging that its baby powder caused ovarian cancer. The company is attempting to resolve over 62,000 lawsuits by using a subsidiary’s bankruptcy, a tactic it has tried twice before but was rejected. This third attempt is supported by votes showing broad backing for the settlement, which J&J argues offers a faster and fairer recovery for cancer victims than lengthy trials. However, opponents claim the bankruptcy settlement unfairly forces women to accept lower payments and limits their ability to litigate their cases. The judge will consider a wide range of evidence in the coming weeks, including the validity of the votes and whether a wealthy company should be able to use bankruptcy to protect itself from lawsuits. The outcome will be decided by the end of February. (Reuters)
PLANT-BASED MEATS OFFER HEALTH BENEFITS BUT REQUIRE CAUTION
Plant-based meat alternatives like those from Beyond Meat and Impossible Foods are made from plants but are highly processed. These products typically contain less saturated fat than real meat, similar protein levels, and some fiber, which real meat lacks. However, they often have more sodium than unprocessed meats. While early studies show mixed results, some suggest that plant-based meats may offer health benefits, such as lower cholesterol, but larger, longer-term studies are needed for clearer conclusions. Despite being classified as ultraprocessed foods, which have been linked to health risks, experts caution that not all processed foods are harmful, and plant-based meats are less concerning than sugary drinks or processed meats. Nutritionists agree that reducing red and processed meat in favor of whole plant foods like beans, lentils, and tofu is a better choice for health and the environment. Plant-based meats can be a steppingstone toward a healthier, more plant-forward diet. (New York Times)
RESEARCHERS DISCOVER PLEASANT SCENT FROM WELL-PRESERVED EGYPTIAN MUMMIES
Researchers at University College London have discovered that the scent of well-preserved Egyptian mummies is surprisingly pleasant, contrary to the typical portrayal of decaying bodies in media. The study, published in the Journal of the American Chemical Society, analyzed the odors from nine mummies aged up to 5,000 years. Using both chemical analysis and human smell panels, they described the aromas as “woody,” “spicy,” and “sweet,” with floral notes possibly due to pine and juniper resins used in embalming. The team was relieved to find no signs of microbial degradation or decaying bodies, indicating good preservation conditions at the Egyptian Museum in Cairo. This research, which avoids invasive methods, offers insight into the preservation of ancient remains and could assist in protecting them for future generations. Researchers hope their findings can help recreate “smellscapes” to enhance museum experiences, offering a more immersive understanding of ancient practices. (AP)
Leave a Reply